Trastuzumab, a breast cancer drug, was accessed by only 1% of eligible patients in India five years ago.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.